findmyKOL

Mary Dooley, MD

Enriched profile

Rheumatologist, UNC Physicians Network (UNC Specialty Care) · UNC Health

ORCIDNone on fileNPI↗
✓ Full profile
Region🇺🇸 Clayton, NC · Southeast · United StatesSpecialtyRheumatologyFocusLupus (SLE)
Active KOLfindmyKOL type: EliteLatest publication2023Online presenceverified 2026Payments2021–2025NIH funding1997–2008Why? →

Mary Dooley is Rheumatologist, UNC Physicians Network (UNC Specialty Care) at UNC Health. ClinicalTrials.gov lists 1 registered study with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 18 Oct 2026

Mary Anne Dooley, MD, is Rheumatologist, UNC Physicians Network (UNC Specialty Care) at UNC Health / UNC Physicians Network. The public record shows 232 publications with 22,183 citations (h-index 59), centered on Lupus (SLE). It also documents an investigator role on 1 registered clinical trials, industry payments reported by 23 companies, 2 NIH-funded awards (1997–2008).

  • Top research focus: Lupus (SLE)
  • 1 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 23 companies

Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Lupus (SLE)1 trialGlomerular Disease1 trialNephritis1 trial

Research focus

OpenAlex concept fingerprint
Lupus (SLE)

Drugs & molecules

across trials, industry payments and publications
Benlystageneric · BelimumabClinical trials—Industry payments60Publications—NirmatrelvirClinical trials—Industry payments8Publications—Xeljanzgeneric · TofacitinibClinical trials—Industry payments8Publications—Cimziageneric · Certolizumab pegolClinical trials—Industry payments7Publications—Wegovygeneric · SemaglutideClinical trials—Industry payments7Publications—Bimzelxgeneric · BimekizumabClinical trials—Industry payments6Publications—Otezlageneric · ApremilastClinical trials—Industry payments6Publications—Tremfyageneric · GuselkumabClinical trials—Industry payments5Publications—SIMPONI ARIAClinical trials—Industry payments4Publications—Jardiancegeneric · EmpagliflozinClinical trials—Industry payments3Publications—Lupkynisgeneric · VoclosporinClinical trials—Industry payments3Publications—Rayosgeneric · PrednisoneClinical trials—Industry payments3Publications—

Works with

trial sponsors and companies reporting payments
GlaxoSmithKline, LLC.Clinical trials—Industry payments60UCB, Inc.Clinical trials—Industry payments14Amgen Inc.Clinical trials—Industry payments10Pfizer Inc.Clinical trials—Industry payments9Novo Nordisk IncClinical trials—Industry payments7Janssen Biotech, Inc.Clinical trials—Industry payments5Lilly USA, LLCClinical trials—Industry payments5Abbvie Inc.Clinical trials—Industry payments4AstraZeneca Pharmaceuticals LPClinical trials—Industry payments4Alexion Pharmaceuticals, Inc.Clinical trials—Industry payments3Aurinia Pharma U.S., Inc.Clinical trials—Industry payments3Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments3Boston Scientific CorporationClinical trials—Industry payments3Exact Sciences CorporationClinical trials—Industry payments3Argenx Us, Inc.Clinical trials—Industry payments2Collegium Pharmaceutical, Inc.Clinical trials—Industry payments2Aurinia Pharmaceuticals Inc.Clinical trials1Industry payments—CSL BehringClinical trials—Industry payments1Eisai Inc.Clinical trials—Industry payments1Genentech USA, Inc.Clinical trials—Industry payments1Horizon Therapeutics plcClinical trials—Industry payments1Novartis Pharmaceuticals CorporationClinical trials—Industry payments1Sandoz Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
59h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials ↓
23companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
2NIH grants · 1997–2008

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 18 Oct 2026

Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:

Industry payments

Updated 18 Oct 2026

23 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    32.4%
    Folate Analog Metabolic Inhibitor16.5%
    Methotrexate100%
    Part D≥80 patients
    TNF inhibitor7.7%
    Humira(Cf) Pen41%Enbrel Sureclick37%Cimzia (2 Pack)14%Enbrel9%
    Part D<11 patients

    + 5 more classes in this area

  • Metabolism & gastrointestinal

    31.1%
    Corticosteroid24.9%
    Prednisone100%
    Part D≥156 patients
    Proton pump inhibitor2.6%
    Omeprazole69%Pantoprazole Sodium31%
    Part D<11 patients

    + 3 more classes in this area

  • Antiparasitic

    18.1%
    Antimalarial18.1%
    Hydroxychloroquine Sulfate100%
    Part D≥90 patients
All 8 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 18 Oct 2026

2 NIH research awards on record, funded 1997–2008 per NIH RePORTER. The latest:

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Online presence

Updated 18 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/mary-anne-dooley-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • ResearchGate

    researchgate.net/profile/Mary-Dooley

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗

Mentions by others

where others cite or feature them
  • Other

    ncrheum.org/doctors/mary-anne-dooley

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ncrheum.org ↗
  • Other

    lupus.org/resources/lupus-media-library

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lupus.org ↗
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 18 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    University of North Carolina School of Medicine

    1983
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗
  • MPH

    University of North Carolina at Chapel Hill

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unchealth.org ↗
  • Board Certified

    American Board of Internal Medicine (Internal Medicine, subspecialty Rheumatology)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗
  • Internal Medicine residency and chief residency

    University of Massachusetts Medical Center

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.unchealthcare.org ↗
  • Rheumatology and Immunology fellowship

    Duke University Medical Center

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.unchealthcare.org ↗

Editorial & leadership roles

journal and society appointments
  • Acting Division Chief

    UNC Rheumatology and Immunology (approx. 4 years)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.unchealthcare.org ↗
  • Contributor

    Lupus Clinical Trials Consortium

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
  • Member

    Lupus Foundation of America Medical and Scientific Advisory Committee (widely repeated in secondary physician-directory sources …

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →lupus.org ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.